U.S. Pharmaceuticals & Biotech High Growth Potential Companies

Bruker

Market Cap: US$5.6b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Emergent BioSolutions

Market Cap: US$350.6m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Neurocrine Biosciences

Market Cap: US$12.2b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Jazz Pharmaceuticals

Market Cap: US$6.7b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

MDxHealth

Market Cap: US$104.2m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Phibro Animal Health

Market Cap: US$989.8m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

Incyte

Market Cap: US$12.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Xeris Biopharma Holdings

Market Cap: US$791.2m

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

ANI Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Teva Pharmaceutical Industries

Market Cap: US$20.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Repligen

Market Cap: US$6.6b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Ligand Pharmaceuticals

Market Cap: US$2.0b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Mirum Pharmaceuticals

Market Cap: US$2.2b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Esperion Therapeutics

Market Cap: US$168.4m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Mesa Laboratories

Market Cap: US$548.9m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

Organogenesis Holdings

Market Cap: US$361.5m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Sotera Health

Market Cap: US$3.5b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Akebia Therapeutics

Market Cap: US$795.8m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Amneal Pharmaceuticals

Market Cap: US$2.3b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

MannKind

Market Cap: US$1.3b

A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.

Natera

Market Cap: US$21.5b

A diagnostics company, provides molecular testing services worldwide.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Viatris

Market Cap: US$10.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Organon

Market Cap: US$2.4b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Qiagen

Market Cap: US$9.8b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Stevanato Group

Market Cap: US$6.1b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Cassava Sciences

Market Cap: US$97.1m

A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.

Tempus AI

Market Cap: US$9.6b

Operates as a healthcare technology company.

Bausch Health Companies

Market Cap: US$1.7b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Grace Therapeutics

Market Cap: US$38.0m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Caribou Biosciences

Market Cap: US$98.6m

A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.

Supernus Pharmaceuticals

Market Cap: US$1.8b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Bio-Path Holdings

Market Cap: US$1.4m

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

Bio-Techne

Market Cap: US$7.6b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Azenta

Market Cap: US$1.2b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.